Multiplex real-time PCR FilmArray performance in the diagnosis of meningoencephalitis: lights and shadows.

BioFire Encephalitis Meningitis Meningoencephalitis Multiplex real-time PCR

Journal

Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307

Informations de publication

Date de publication:
29 Jul 2023
Historique:
received: 19 06 2023
accepted: 13 07 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: aheadofprint

Résumé

We aimed to evaluate the performance of the FilmArray (FA) meningitis/encephalitis (ME) panel. Secondarily, we analyzed the false positive (FP) and false negative (FN) results, as well as the predictive values of the technique, regarding the cerebrospinal fluid (CSF) characteristics. FA is a multiplex real-time PCR detecting 14 of the most common ME pathogens in CSF. All FA performed at our hospital (2018-2022) were retrospectively reviewed. FA was compared to conventional techniques and its performance was assessed based on the final diagnosis of the episode. FA was performed in 313 patients with suspicion of ME. Most patients had altered mental status (65.2%) and fever (61%). Regarding CSF characteristics, 49.8% and 53.7% presented high CSF proteins and pleocytosis, respectively. There were 84 (26.8%) positive FA results, mainly for HSV-1 (10.9%), VZV (5.1%), Enterovirus (2.6%), and S. pneumoniae (1.9%). In the 136 cases where both FA and routine methods were performed, there was a 25.7% lack of agreement. We identified 6.6% FN results, but 28.6% FP, mainly due to HSV-1. This resulted in a high negative predictive value (NPV) of 93.4%, but a positive predictive value (PPV) of 73%. Remarkably, PPV as low as 36.9%, and 70.2%, were found in cases without pleocytosis, or lack of high CSF protein levels, respectively. FA was associated with high NPV, but frequent FP results and low PPV, particularly for HSV-1, and especially in patients without high CSF protein levels or pleocytosis.

Identifiants

pubmed: 37515691
doi: 10.1007/s15010-023-02076-x
pii: 10.1007/s15010-023-02076-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : JR20/00012
Organisme : Instituto de Salud Carlos III
ID : PI21/00498
Organisme : Instituto de Salud Carlos III
ID : ICI21/00103

Informations de copyright

© 2023. The Author(s).

Références

Meningitis—Level 3 cause | Institute for Health Metrics and Evaluation. https://www.healthdata.org/results/gbd_summaries/2019/meningitis-level-3-cause . Retrieved 6 March 2023.
Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:317–28.
doi: 10.1016/S1473-3099(10)70048-7 pubmed: 20417414
Dorsett M, Liang SY. Diagnosis and treatment of central nervous system infections in the emergency department. Emerg Med Clin North Am. 2016;34:917–42.
doi: 10.1016/j.emc.2016.06.013 pubmed: 27741995 pmcid: 5082707
Brouwer MC, Tunkel AR, Van De Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23:467–92.
doi: 10.1128/CMR.00070-09 pubmed: 20610819 pmcid: 2901656
Cailleaux M, Pilmis B, Mizrahi A, Lourtet-Hascoet J, Van JCN, Alix L, Couzigou C, Vidal B, Tattevin P, Le Monnier A. Impact of a multiplex PCR assay (FilmArray®) on the management of patients with suspected central nervous system infections. Eur J Clin Microbiol Infect Dis. 2020;39:293–7.
doi: 10.1007/s10096-019-03724-7 pubmed: 31720944
Biofire Diagnostics. 2020. BioFire FilmArray Meningitis/Encephalitis Panel (ME) | BioFire Diagnostics. https://www.biofiredx.com/products/the-filmarray-panels/filmarrayme/ . Retrieved 6 March 2023.
Tansarli GS, Chapin KC. Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis. Clin Microbiol Infect. 2020;26:281–90.
doi: 10.1016/j.cmi.2019.11.016 pubmed: 31760115
Trujillo-G Omez J, Tsokani S, Arango-Ferreira C, Atehort Ua-Mu~ S, Jos E Jimenez-Villegas M, Serrano-Tabares C, Veroniki A-A, Florez ID. Biofire FilmArray Meningitis/Encephalitis panel for the aetiological diagnosis of central nervous system infections: A systematic review and diagnostic test accuracy meta-analysis. eClinicalMedicine. 2022;44:101275.
Moffa MA, Bremmer DN, Carr D, Buchanan C, Shively NR, Elrufay R, Walsh TL. Impact of a multiplex polymerase chain reaction assay on the clinical management of adults undergoing a lumbar puncture for suspected community-onset central nervous system infections. Antibiotics. 2020;9:282.
doi: 10.3390/antibiotics9060282 pubmed: 32466378 pmcid: 7344633
Vincent JJ, Zandotti C, Baron S, Kandil C, Levy PY, Drancourt M, Raoult D, Ninove L. Point-of-care multiplexed diagnosis of meningitis using the FilmArray® ME panel technology. Eur J Clin Microbiol Infect Dis. 2020;39:1573–80.
doi: 10.1007/s10096-020-03859-y pubmed: 32358740
Leber AL, Everhart K, Balada-Llasat JM, Cullison J, Daly J, Holt S, Lephart P, Salimnia H, Schreckenberger PC, DesJarlais S, Reed SL, Chapin KC, LeBlanc L, Johnson JK, Soliven NL, Carroll KC, Miller JA, Bard JD, Mestas J, Bankowski M, Enomoto T, Hemmert AC, Bourzac KM. Multicenter evaluation of biofire filmarray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54:2251–61.
doi: 10.1128/JCM.00730-16 pubmed: 27335149 pmcid: 5005480
Lindström J, Elfving K, Lindh M, Westin J, Studahl M. Assessment of the FilmArray ME panel in 4199 consecutively tested cerebrospinal fluid samples. Clin Microbiol Infect. 2022;28:79–84.
doi: 10.1016/j.cmi.2021.05.017 pubmed: 34015534
Hanson KE, Slechta ES, Killpack JA, Heyrend C, Lunt T, Daly JA, Hemmert AC, Blaschke AJ. preclinical assessment of a fully automated multiplex PCR panel for detection of central nervous system pathogens. J Clin Microbiol. 2016;54:785–7.
doi: 10.1128/JCM.02850-15 pubmed: 26719436 pmcid: 4767945
Liesman RM, Strasburg AP, Heitman AK, Theel ES, Patel R, Binnicker MJ. Evaluation of a commercial multiplex molecular panel for diagnosis of infectious meningitis and encephalitis. J Clin Microbiol. 2018;56:e01927-e2017.
doi: 10.1128/JCM.01927-17 pubmed: 29436421 pmcid: 5869843
Radmard S, Reid S, Ciryam P, Boubour A, Ho N, Zucker J, Sayre D, Greendyke WG, Miko BA, Pereira MR, Whittier S, Green DA, Thakur KT. Clinical utilization of the filmarray meningitis/encephalitis (ME) multiplex polymerase chain reaction (PCR) assay. Front Neurol. 2019;10:281.
doi: 10.3389/fneur.2019.00281 pubmed: 30972012 pmcid: 6443843
Bronska E, Kalmusova J, Dzupova O, Maresova V, Kriz P, Benes J. Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease. Clin Microbiol Infect. 2006;12:137–41.
doi: 10.1111/j.1469-0691.2005.01327.x pubmed: 16441451
Seth R, Murthy PSR, Sistla S, Subramanian M, Tamilarasu K. Rapid and accurate diagnosis of acute pyogenic meningitis due to Streptococcus pneumoniae, Haemophilus influenzae type b and Neisseria meningitidis using a multiplex PCR assay. J Clin Diagnostic Res. 2017;11:FC01–FC04.
Markovich K, Wingler MJB, Stover KR, Barber KE, Wagner JL, Cretella DA. Analysis of the clinical impact of the BioFire FilmArray meningitis encephalitis panel on antimicrobial use and duration of therapy at an academic medical center. Diseases. 2022;10:110.
doi: 10.3390/diseases10040110 pubmed: 36412604 pmcid: 9680255
DiDIodato G, Bradbury N. Cerebrospinal fluid analysis with the biofire filmarray meningitis/ encephalitis molecular panel reduces length of hospital stay in patients with suspected central nervous system infections. Open Forum Infect Dis. 2019;6:ofz119.

Auteurs

Néstor López (N)

Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.

Genoveva Cuesta (G)

Microbiology Department, Hospital Clinic, University of Barcelona, ISGLOBAL, Barcelona, Spain.

Sara Rodríguez-Vega (S)

Hospital Universitario de Cabueñes, Gijón, Spain.

Enric Rosas (E)

Microbiology Department, Hospital Clinic, University of Barcelona, ISGLOBAL, Barcelona, Spain.

Mariana Chumbita (M)

Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.

Climent Casals-Pascual (C)

Microbiology Department, Hospital Clinic, University of Barcelona, ISGLOBAL, Barcelona, Spain.
CIBERINF, CIBER Infectious Diseases, Madrid, Spain.
Universitat de Barcelona (UB), Barcelona, Spain.

Laura Morata (L)

Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Universitat de Barcelona (UB), Barcelona, Spain.

Andrea Vergara (A)

Microbiology Department, Hospital Clinic, University of Barcelona, ISGLOBAL, Barcelona, Spain.

Marta Bodro (M)

Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
Universitat de Barcelona (UB), Barcelona, Spain.

Jordi Bosch (J)

Microbiology Department, Hospital Clinic, University of Barcelona, ISGLOBAL, Barcelona, Spain.
Universitat de Barcelona (UB), Barcelona, Spain.

Sabina Herrera (S)

Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.

Jose Antonio Martínez (JA)

Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
CIBERINF, CIBER Infectious Diseases, Madrid, Spain.
Universitat de Barcelona (UB), Barcelona, Spain.

Josep Mensa (J)

Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.

Carolina Garcia-Vidal (C)

Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
CIBERINF, CIBER Infectious Diseases, Madrid, Spain.
Universitat de Barcelona (UB), Barcelona, Spain.

María Ángeles Marcos (MÁ)

Microbiology Department, Hospital Clinic, University of Barcelona, ISGLOBAL, Barcelona, Spain.
CIBERINF, CIBER Infectious Diseases, Madrid, Spain.
Universitat de Barcelona (UB), Barcelona, Spain.

Jordi Vila (J)

Microbiology Department, Hospital Clinic, University of Barcelona, ISGLOBAL, Barcelona, Spain.
CIBERINF, CIBER Infectious Diseases, Madrid, Spain.
Universitat de Barcelona (UB), Barcelona, Spain.

Alex Soriano (A)

Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain.
CIBERINF, CIBER Infectious Diseases, Madrid, Spain.
Universitat de Barcelona (UB), Barcelona, Spain.

Pedro Puerta-Alcalde (P)

Infectious Diseases Department, Hospital Clínic-IDIBAPS, Barcelona, Spain. pedro.puerta84@gmail.com.
Universitat de Barcelona (UB), Barcelona, Spain. pedro.puerta84@gmail.com.

Classifications MeSH